Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Ridley

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2007
International price comparisons for novel and follow-on drugsDavid B Ridley
The American Journal of Tropical Medicine and Hygiene|August 31, 2016
Priorities for the Priority Review VoucherDavid B Ridley
Health Economics|December 11, 2014
Payments, promotion, and the purple pillDavid B Ridley
Pharmacoeconomics|July 1, 2005
Price differentiation and transparency in the global pharmaceutical marketplaceDavid B Ridley
Lancet (London, England)|September 14, 2010
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseasesDavid B Ridley, Alfonso Calles Sánchez
Health Affairs (Project Hope)|September 13, 2007
Would greater transparency and uniformity of health care prices benefit poor patients?Margaret K Kyle, David B Ridley
Health Affairs (Project Hope)|May 4, 2016
The Commercial Market For Priority Review VouchersDavid B Ridley, Stephane A Régnier
Nature Reviews. Drug Discovery|August 15, 2015
Market watch: Forecasting market share in the US pharmaceutical marketStephane A Regnier, David B Ridley
The Journal of Ambulatory Care Management|August 4, 2004
Differential pricing of pharmaceuticals in the internet ageDavid B Ridley, Kevin A Schulman
Pharmacoeconomics|February 3, 2007
Impact of Medicaid preferred drug lists on therapeutic adherenceDavid B Ridley, Kirsten J Axelsen
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2007
International price comparisons for novel and follow-on drugsDavid B Ridley
The American Journal of Tropical Medicine and Hygiene|August 31, 2016
Priorities for the Priority Review VoucherDavid B Ridley
Health Economics|December 11, 2014
Payments, promotion, and the purple pillDavid B Ridley
Pharmacoeconomics|July 1, 2005
Price differentiation and transparency in the global pharmaceutical marketplaceDavid B Ridley
Lancet (London, England)|September 14, 2010
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseasesDavid B Ridley, Alfonso Calles Sánchez
Health Affairs (Project Hope)|September 13, 2007
Would greater transparency and uniformity of health care prices benefit poor patients?Margaret K Kyle, David B Ridley
Health Affairs (Project Hope)|May 4, 2016
The Commercial Market For Priority Review VouchersDavid B Ridley, Stephane A Régnier
Nature Reviews. Drug Discovery|August 15, 2015
Market watch: Forecasting market share in the US pharmaceutical marketStephane A Regnier, David B Ridley
The Journal of Ambulatory Care Management|August 4, 2004
Differential pricing of pharmaceuticals in the internet ageDavid B Ridley, Kevin A Schulman
Pharmacoeconomics|February 3, 2007
Impact of Medicaid preferred drug lists on therapeutic adherenceDavid B Ridley, Kirsten J Axelsen
Pageof 3